Introduction to Chemotherapy

Historical Context

• 1950s and 60s: Discovery and integration of chemotherapy into cancer treatment.
• Prior Treatment: Surgery was the primary method; radiotherapy also emerged.
• Madame Curie: Contributed to nuclear medicine research.

Importance of Chemotherapy

• Curative Potential: Initially successful in curing cancer, led to multimodal treatment strategies.
• Toxicity Issues: Cannot distinguish between normal and abnormal dividing cells, leading to general toxicity.
• Drug Resistance: Prolonged use can lead to resistance, reducing effectiveness.

Historical Development

• Accidental Discovery: During World Wars I & II, nitrogen mustard was found to affect bone marrow.
• First Use: 1943 for hematological malignancies.
• Key Figure: Bernard Fisher, known as the father of chemotherapy.

Usage of Chemotherapy

Types of Treatments

• Primary Treatment: For blood cancers like leukemia and lymphoma.
• Induction and Maintenance: High initial dose followed by maintenance doses for cancers like hematological malignancies and osteosarcoma.
• Neoadjuvant: Administered before surgery or radiation to reduce tumor size and facilitate organ preservation.
• Adjuvant: Given after surgery/radiation to reduce recurrence and improve survival.
• Concomitant Chemo-radiation: Given simultaneously with radiation to maximize effectiveness.
• Direct Installation: Into body cavities for cancers like peritoneal irrigations.
• Palliation: For symptom relief when curative treatment is not possible.

Measuring Effectiveness and Toxicity

• RECIST: Response Evaluation Criteria in Solid Tumors for measuring patient response.
• WHO Criteria: For drug toxicity, classifying into grades 1, 2, and 3.

Response Categories

• Partial Response: 30% reduction in tumor size.
• Complete Response: Tumor completely disappears.
• Stable Disease: No change in size.
• Progressive Disease: Tumor increases by 20% or new lesions appear.

Kinetics and Models

Cell Kinetics

• Exponential Growth: From single cell to multiple cells (e.g., reproduction).
• Logarithmic Cell Kill: Chemotherapy kills a set number of cells each time, leading to a reduction in tumor size in a logarithmic manner.
• Gompertzian Model: Tumor growth slows over time due to cell death and limited resources.
• Optimal Timing: Early intervention is crucial for better cell kill rates and survival outcomes.

Combination Chemotherapy

• Advantages: Reduces drug resistance and enhances effectiveness, but needs careful selection to avoid overlapping toxicities.
• Rules for Combination: Use drugs from different classes with maximum individual effectiveness and non-overlapping toxicities.

Types of Chemotherapy Agents

Alkylating Agents

• Mechanism: Introduce alkyl groups into DNA, causing dysfunction or breakage.
• Examples: Nitrogen mustards, aziridines, and epoxides.

Platinum Compounds

• Mechanism: Bind to DNA bases, causing adduct formation.
• Examples: Cisplatin (nephrotoxic), carboplatin, and oxaliplatin.

Antimetabolites

• Mechanism: Inhibit folate metabolism and thymidine synthetase.
• Examples: Methotrexate, 5-fluorouracil, and capecitabine.

Topoisomerase Inhibitors

• Mechanism: Interfere with DNA packaging/unpackaging.
• Examples: Camptothecins, epipodophyllotoxins, anthracyclines.

Antimicrotubule Agents

• Mechanism: Inhibit microtubule formation during cell division.
• Examples: Vincristine, paclitaxel.

Miscellaneous Agents

• Mechanisms: Various unique mechanisms.
• Examples: L-asparaginase, bleomycin.

Tyrosine Kinase Inhibitors

• Mechanism: Inhibit specific tyrosine kinase enzymes crucial for cell cycle.
• Examples: Imatinib (BCR-ABL inhibitor), gefitinib (EGFR inhibitor).

Emerging and Specialized Agents

• Examples: Bortezomib, a proteasome inhibitor used for multiple myeloma.